Your skin has been drier than usual lately. Not dramatically so — just a persistent dullness that moisturizer doesn’t quite fix. You’ve been in a low mood more often than feels normal for you. Your joints ache a little more than they used to, especially in the morning. Your eyes feel gritty and tired, even after a full night’s sleep.
Individually, each of these things has an explanation. Together, they might be pointing to something you haven’t considered: your Omega-3 intake may not be where it should be.
Here’s the honest framing upfront. True Omega-3 deficiency — the clinical kind — is rare in countries where food is plentiful. What’s far more common is chronic inadequacy: getting enough Omega-3 to avoid severe symptoms, but not enough to support optimal function in the areas where these fatty acids matter most — your brain, your eyes, your skin, your joints, and your cardiovascular system. The line between “deficiency” and “inadequacy” is blurry in everyday experience. What you feel is the same.
This guide covers what Omega-3 inadequacy actually looks like, who’s most likely to be running low, and how to assess whether this is worth paying attention to in your own situation.
Key Takeaways
- True severe Omega-3 deficiency is rare, but chronic inadequacy — getting less than your body needs for optimal function — is common, particularly in people eating Western diets low in fatty fish.
- The NIH reports that EPA and DHA levels in the red blood cells of Western adults not taking supplements average just 3–5% of total fatty acids, compared to roughly double that in Japanese populations with high fish consumption.
- ALA (the plant-based Omega-3 found in flaxseed and walnuts) converts to EPA and DHA at rates of less than 15% in the human body — meaning plant-based Omega-3 intake alone may not raise EPA and DHA levels meaningfully.
- The most commonly reported signs of Omega-3 inadequacy include dry or rough skin, dry eyes, low mood, difficulty concentrating, joint stiffness, and increased susceptibility to infections.
- These symptoms are nonspecific — they overlap with many other conditions. The value in recognizing them is not diagnosing deficiency, but prompting you to assess your actual EPA and DHA intake.
What Are Omega-3 Fatty Acids and Why Does Inadequacy Matter?
Omega-3 fatty acids aren’t a single nutrient — they’re a family of polyunsaturated fats, three of which matter most for human health:
ALA (alpha-linolenic acid): Found in plant foods — flaxseed, chia seeds, walnuts, canola oil. ALA is technically an essential fatty acid (the body can’t make it), but its biological roles in the body are limited compared to EPA and DHA. Most dietary ALA is burned for energy rather than converted into the long-chain forms that have the most physiological impact.
EPA (eicosapentaenoic acid): Found in fatty fish, fish oil, and algae. EPA is primarily involved in producing eicosanoids — signaling molecules that regulate inflammation, blood clotting, and immune responses. Higher EPA levels are associated with reduced inflammatory activity, which has downstream effects on joint health, cardiovascular function, and mood regulation.
DHA (docosahexaenoic acid): Found in fatty fish, fish oil, krill oil, and algal oil. DHA is a structural component of cell membranes — particularly concentrated in the retina, brain tissue, and sperm. It’s not primarily a signaling molecule like EPA; it’s a building material. The brain is approximately 60% fat by dry weight, and DHA is the predominant structural omega-3 in neural tissue.
The reason EPA and DHA inadequacy has broad physiological effects is that these fatty acids are embedded in the architecture of nearly every cell membrane in the body. When they’re present in adequate concentrations, cell membranes are more fluid and responsive. When they’re chronically low, cell function across multiple systems is subtly compromised — not dramatically broken, but running below its potential.
Signs of Omega-3 Deficiency: What Low Intake Can Look Like
These symptoms don’t prove Omega-3 inadequacy — each one has multiple possible causes. What they represent, in combination, is a pattern worth paying attention to.
Dry, Dull, or Rough Skin
Omega-3 fatty acids are components of the lipid barrier in skin — the protective layer that holds moisture in and prevents environmental irritants from penetrating. When EPA and DHA are chronically low, skin barrier function can be subtly compromised, resulting in dryness, roughness, and increased sensitivity. This is one of the more consistently reported early signs of inadequate Omega-3 intake in research settings.
Eczema (atopic dermatitis) has been associated with low Omega-3 status in multiple observational studies. While the relationship isn’t definitively causal, people with eczema are sometimes found to have lower circulating EPA and DHA levels than healthy controls.
The distinction to make: This isn’t the acute, cracked skin of severe essential fatty acid deficiency (which is truly rare). It’s a persistent dullness and dryness that doesn’t respond fully to moisturizers — a barrier-function issue rather than a surface moisture issue.
Dry Eyes and Visual Fatigue
DHA is present in exceptionally high concentrations in the retina — it makes up a significant proportion of the photoreceptor outer segments in the rod and cone cells that convert light into neural signals. This isn’t a coincidence: DHA’s structural properties (its long chain and high degree of unsaturation) make it particularly suited to the highly fluid, rapidly responding membranes of retinal cells.
Low DHA intake is associated with reduced tear production and dry eye symptoms — the gritty, fatigued feeling that can develop from inadequate ocular surface lubrication. This is more relevant in the current environment of prolonged screen use, which itself reduces blink rate and speeds tear evaporation. People who spend extended hours in front of screens and consume little EPA and DHA may be compounding a structural deficit with a behavioral one.
Low Mood, Irritability, or Mental Flatness
DHA and EPA both appear to influence mood regulation, though through different mechanisms. DHA’s structural role in neuronal cell membranes affects neurotransmitter signaling — particularly serotonin and dopamine pathways. EPA is converted into anti-inflammatory eicosanoids that reduce neuroinflammation, which has emerged as a significant factor in depressive disorders.
A meta-analysis of randomized controlled trials found that Omega-3 supplementation — particularly EPA at doses above 1 gram/day — produced statistically significant improvements in depressive symptoms. The effect was most pronounced when EPA was the predominant component relative to DHA, and most relevant when baseline depression was mild to moderate rather than severe.
This doesn’t mean Omega-3 inadequacy causes depression. It means the mood-related symptom pattern associated with low Omega-3 — low baseline mood, reduced emotional resilience, subtle irritability, mental flatness — may partly reflect neurobiological effects of EPA and DHA insufficiency.
Difficulty Concentrating or Brain Fog
This is one of the harder symptoms to attribute clearly, because “brain fog” and difficulty concentrating have dozens of causes. But given DHA’s structural role in brain tissue — it’s the dominant omega-3 in the neural cell membranes that govern synaptic function and neurotransmitter release — it’s mechanistically plausible that chronically low DHA would affect cognitive clarity.
Observational studies in adults have found associations between higher DHA intake or status and better performance on tasks involving attention, processing speed, and working memory. Intervention trials in adults without diagnosed cognitive conditions show more variable results, but the direction is consistently positive at adequate doses.
Joint Stiffness and Discomfort, Especially in the Morning
EPA and DHA modify the balance of inflammatory eicosanoids — signaling molecules derived from fatty acids that regulate inflammatory responses in joints and throughout the body. When EPA and DHA concentrations are higher relative to arachidonic acid (an omega-6 fatty acid), the eicosanoid balance shifts toward less inflammatory activity.
Joint stiffness that’s worse in the morning — the characteristic pattern of inflammatory joint discomfort — can be related to elevated inflammatory activity overnight. Several clinical trials in people with rheumatoid arthritis have shown meaningful reductions in morning stiffness and joint tenderness with EPA+DHA supplementation at doses of 2–3 grams/day. For healthy people with mild joint discomfort, the evidence is less clear but mechanistically consistent.
Frequent Infections or Slow Recovery
EPA and DHA influence both innate and adaptive immune function. They modulate the inflammatory response in ways that affect how efficiently the immune system mounts and resolves responses to pathogens. Chronically low EPA and DHA may be associated with a slightly higher frequency of common infections or longer recovery time — though this is one of the less well-characterized symptoms because immune function is affected by so many variables simultaneously.
Low Omega-3 Symptoms: Who Is Most at Risk
Not everyone’s Omega-3 status is equally vulnerable. These groups tend to have higher risk of chronic inadequacy:
People who eat little or no fatty fish. The primary dietary source of EPA and DHA is cold-water fatty fish — salmon, mackerel, sardines, herring, anchovies. Three ounces of farmed Atlantic salmon provides approximately 1.83 grams of EPA+DHA combined. People who don’t eat fatty fish at least twice weekly have limited dietary EPA and DHA intake, and — crucially — cannot compensate effectively through plant-based ALA.
People who rely on plant sources as their primary Omega-3. This is the most important and most misunderstood point: ALA converts to EPA and DHA in the human liver, but at rates below 15% for EPA conversion and even lower for DHA. In practical terms, a tablespoon of flaxseed oil provides approximately 7.26 grams of ALA — which converts to perhaps 0.5–1 gram of EPA and significantly less DHA. This is meaningful but not equivalent to consuming EPA and DHA directly from fish or algal oil. Vegans and strict vegetarians who are not using algal oil (a direct DHA+EPA source) are at meaningful risk of DHA inadequacy specifically.
Pregnant and breastfeeding women. DHA is actively transferred to the fetus during pregnancy, particularly during the third trimester when neural development is most rapid. Maternal DHA status decreases during pregnancy unless intake is sufficient to compensate for placental transfer. The developing fetal brain prioritizes DHA accumulation — which can draw significantly from maternal stores if dietary intake is inadequate.
Older adults. The conversion of ALA to EPA and DHA becomes less efficient with age. Older adults also tend to eat less overall, reducing dietary EPA and DHA from food. Combined with the cognitive and cardiovascular relevance of adequate EPA and DHA in aging populations, this makes older adults a higher-risk group for inadequacy.
People with conditions affecting fat absorption. Omega-3 fatty acids are fats — they require functional fat absorption from the gut. People with Crohn’s disease, celiac disease, or after bariatric surgery may absorb Omega-3s less efficiently from both food and supplements.
People with high omega-6 intake relative to omega-3. Western diets are heavily weighted toward omega-6 fatty acids (from vegetable oils, processed foods, grain-fed meat). Since omega-6 and omega-3 fatty acids compete for the same desaturation and elongation enzymes, a high omega-6 to omega-3 ratio can further limit EPA and DHA synthesis from ALA. The average Western diet has an omega-6 to omega-3 ratio of approximately 15:1 to 20:1, compared to a ratio of roughly 4:1 in populations with better health outcomes.
Plant-Based Omega-3: What It Does and Doesn’t Provide
This section is for anyone who is vegetarian, vegan, or who relies primarily on plant foods for Omega-3 intake — because the picture here is more nuanced than most people realize.
ALA-rich plant foods (flaxseed, chia seeds, walnuts, hemp seeds, canola oil) do provide the essential fatty acid ALA, and consuming them regularly is nutritionally meaningful. But ALA is not the same as EPA and DHA. The conversion pathway exists in humans, but the conversion rates are low — less than 15% to EPA, and a fraction of that to DHA.
What this means in practice: Someone eating a diet rich in ALA but with no direct EPA or DHA sources — and not using algal oil supplementation — is likely to have lower circulating EPA and DHA levels than someone who eats fatty fish or uses a fish/algal oil supplement. The NIH data shows that EPA+DHA in the erythrocytes of Japanese populations (with high fish consumption) are roughly double those of Western populations. Vegans typically show even lower levels than average Western adults.
The solution for plant-based eaters: Algal oil. This is the supplement form that provides EPA and DHA directly from microalgae — the same source that fish accumulate their omega-3s from in the first place. Algal oil is molecularly equivalent to fish-derived EPA and DHA, and a small study found the bioavailability of DHA from algal oil to be equivalent to that from cooked salmon. For vegans and vegetarians who want to maintain adequate EPA and DHA status without fish or fish oil, algal oil is the direct solution.
How to Assess Your Own Omega-3 Intake
You don’t need a blood test to get a rough picture of your EPA and DHA intake — though testing exists and can be useful. A practical self-assessment:
Step 1: Count your fatty fish servings per week. A 3-ounce serving of salmon provides approximately 1.8 grams of EPA+DHA. Two servings per week provides roughly 3.6 grams, or about 500 mg/day — near the range associated with cardiovascular benefit in research. If you’re eating zero to one servings of fatty fish per week, your dietary EPA+DHA is likely low.
Step 2: Check whether you’re taking an Omega-3 supplement. Fish oil, krill oil, and algal oil all provide EPA and DHA directly. A standard fish oil capsule typically provides about 300 mg combined EPA+DHA. Whether this is adequate depends on your dietary intake and individual needs.
Step 3: Assess the symptom pattern. The symptoms above — dry skin, dry eyes, low mood, joint stiffness — don’t confirm low Omega-3 intake, but if several apply to you simultaneously and you eat little fatty fish and no EPA/DHA supplement, the probability that inadequate intake is contributing is meaningful.
Blood testing: An omega-3 index test measures EPA+DHA as a percentage of total red blood cell fatty acids. Values below 4% are considered low; values of 8–12% are considered optimal by researchers like Dr. William Harris, who developed the omega-3 index metric. This test is available through some primary care providers and direct-to-consumer testing services.
When to Talk to a Doctor
Most Omega-3 inadequacy is a nutritional gap that can be addressed through diet and supplementation — it’s not a medical emergency. Talk to your doctor if:
- You’re pregnant or planning to become pregnant — DHA intake during pregnancy is important for fetal brain development and worth discussing with your OB
- You have a diagnosed inflammatory condition (rheumatoid arthritis, inflammatory bowel disease) and are considering higher-dose EPA+DHA supplementation
- You take blood-thinning medications (warfarin, aspirin at therapeutic doses, other anticoagulants) — high-dose fish oil has blood-thinning effects and potential interactions
- You have a significant mood disorder — Omega-3 supplementation can be a useful adjunct, but should not replace professional evaluation and treatment
- You’re experiencing severe dry eye symptoms that aren’t improving with standard treatments
Frequently Asked Questions
What are the symptoms of Omega-3 deficiency? The most commonly reported signs of Omega-3 inadequacy include dry or rough skin, dry eyes, low or flat mood, difficulty concentrating, joint stiffness (particularly in the morning), and increased susceptibility to infections. These symptoms are nonspecific — they can have many causes — but they cluster in a recognizable pattern in people with chronically low EPA and DHA intake.
Can you be Omega-3 deficient if you eat flaxseed and walnuts? You can still have low EPA and DHA even with high ALA intake from plant sources. ALA converts to EPA at rates below 15% and to DHA at even lower rates. Flaxseed and walnuts provide meaningful ALA, but they are not reliable sources of EPA or DHA — the long-chain Omega-3s that matter most for brain, eye, and cardiovascular function. Vegans and vegetarians who want adequate EPA and DHA need algal oil.
What does low Omega-3 feel like? There’s no single distinctive feeling. The combination of symptoms most associated with inadequate intake — persistent skin dryness, gritty or fatigued eyes, mood flatness, morning joint stiffness, and cognitive fog — is subtle and easily attributed to other causes. Most people wouldn’t identify these as “Omega-3 symptoms” without being prompted to connect them to dietary patterns.
How do I know if my Omega-3 levels are low? A dietary audit is the first step: how often do you eat fatty fish? Do you take a fish oil, krill oil, or algal oil supplement? If the answer is “rarely” or “never” to both, your EPA and DHA intake is likely below optimal. An omega-3 index blood test (measuring EPA+DHA as a percentage of red blood cell fatty acids) can give you a more precise picture; values below 4% are considered low.
Is Omega-3 deficiency common? Severe clinical deficiency is rare in countries with food security. But chronic inadequacy — intake below what supports optimal function — is common in Western populations, particularly among people who don’t regularly eat fatty fish. The NIH reports that average EPA+DHA in Western adults’ red blood cells is 3–5% of total fatty acids, substantially lower than levels seen in fish-eating populations.
Can low Omega-3 cause depression? Low EPA and DHA status is associated with higher rates of depressive symptoms, and supplementation — particularly EPA-predominant formulations — has shown statistically significant improvements in mild to moderate depressive symptoms in clinical trials. The relationship isn’t straightforwardly causal, and Omega-3s are not a replacement for professional evaluation and treatment of depression. But the neurobiological connection is real and worth considering as part of a comprehensive approach to mood support.
The Bottom Line
Omega-3 deficiency symptoms — in the clinical sense — are rare. But chronic inadequacy of EPA and DHA is common and consequential, particularly in people who don’t regularly eat fatty fish and aren’t supplementing. The symptom pattern it produces is diffuse and easy to miss: dry skin, fatigued eyes, flat mood, stiff joints, foggy thinking. None of these symptoms are dramatic; together they paint a picture of systems running below their potential.
If the pattern resonates, the starting point is a simple dietary audit. How much fatty fish do you actually eat per week? Are you relying on plant-based ALA and assuming it’s doing the job of EPA and DHA? The answers will tell you more than any single supplement decision.
Want to understand what EPA and DHA actually do and how they differ from each other? EPA vs. DHA: What’s the Difference and Which Do You Need? (C3)
Curious about plant-based Omega-3 options and whether algal oil is right for you? Fish Oil vs. Krill Oil vs. Algae Oil: How to Choose (C4)
References
- National Institutes of Health Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. Updated May 2026. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. 2017;45(5):1105-1115. doi:10.1042/BST20160474
- Sublette ME, Ellis SP, Geant AL, Mann JJ. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry. 2011;72(12):1577-1584. doi:10.4088/JCP.10m06634
- Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis. 2017;262:51-54. doi:10.1016/j.atherosclerosis.2017.05.007
- Palacios-Pelaez R, Lukiw WJ, Bazan NG. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Molecular Neurobiology. 2010;41(2-3):367-374. doi:10.1007/s12035-010-8139-z